Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Dec;40(6):954–956. doi: 10.1038/bjc.1979.292

Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.

B M Vose, R Hughes, G W Bazill
PMCID: PMC2010137  PMID: 393293

Full text

PDF
954

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avis F., Mosonov I., Haughton G. Antigenic cross-reactivity between benign and malignant neoplasms of the human breast. J Natl Cancer Inst. 1974 Apr;52(4):1041–1049. doi: 10.1093/jnci/52.4.1041. [DOI] [PubMed] [Google Scholar]
  2. Burtin P., Pinset C., Chany E., Fondaneche M. C., Chavanel G. Leucocyte-migration-inhibition test in patients with colorectal cancer: clinicopathological correlations. Br J Cancer. 1978 Dec;38(6):685–691. doi: 10.1038/bjc.1978.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cannon G. B., McCoy J. L., Jerome L. J., Reddick R., Alford C., Tinley V., Herberman R. B. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay. J Natl Cancer Inst. 1978 Nov;61(5):1181–1186. doi: 10.1093/jnci/61.5.1181. [DOI] [PubMed] [Google Scholar]
  4. Dusheiko G. M., Kew M. C., Rabson A. R. Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma. Br J Cancer. 1979 Sep;40(3):397–402. doi: 10.1038/bjc.1979.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fritze D., Fritze J., Kaufmann M., Drings P. Immundiagnostische Aspekte beim Mammakarzinom. Dtsch Med Wochenschr. 1978 Feb 17;103(7):306–308. doi: 10.1055/s-0028-1104427. [DOI] [PubMed] [Google Scholar]
  6. Grosser N., Thomson D. M. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res. 1975 Sep;35(9):2571–2579. [PubMed] [Google Scholar]
  7. Lopez M., O'Connor R., MacFarlane J. K., Thomson D. M. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition. Br J Cancer. 1978 Dec;38(6):660–673. doi: 10.1038/bjc.1978.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. O'Connor R., MacFarlane J. K., Murray D., Thomson D. M. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay. Br J Cancer. 1978 Dec;38(6):674–684. doi: 10.1038/bjc.1978.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Powell A. E., Sloss A. M., Smith R. N. Leukocyte-adherence inhibition: a specific assay of cell-mediated immunity dependent on lymphokine-mediated collaboration between T lymphocytes. J Immunol. 1978 Jun;120(6):1957–1966. [PubMed] [Google Scholar]
  10. Sanner T., Brennhovd I., Christensen I., Jørgensen O., Kvaløy S. Cellular antitumor immune response in women with risk factors for breast cancer. Cancer Res. 1979 Feb;39(2 Pt 2):654–657. [PubMed] [Google Scholar]
  11. Vose B. M., Kimber I., Moore M. Leukocyte migration inhibition in human pulmonary neoplasia. J Natl Cancer Inst. 1977 Mar;58(3):483–488. doi: 10.1093/jnci/58.3.483. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES